GlassScriptPhysician profile
Huasong Tang
NPI 1861848590
$2,763.24
in general payments reported to CMS, 2019-2025
14 companies · $423 in 2025
The $423 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $1,096 · 2023: $454 · 2024: $560 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,437.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $686.89 | 2021-2025 | Axios, General - Vascular Intervention |
| Medtronic, INC. | $451.01 | 2022 | |
| Siemens Medical Solutions USA, INC. | $434.46 | 2022 | |
| Penumbra, INC. | $332.87 | 2023-2025 | Indigo System, Ruby Coil |
| Balt USA, LLC | $235.16 | 2024 | Prestige Coil System |
| Inari Medical, INC. | $149.76 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $108.02 | 2023-2025 | Jamshidi, Denali Vena Cava Filter |
| Stryker Corporation | $85.85 | 2022-2025 | Revcore Thrombectomy Catheter, Flowtriever |
| Terumo Medical Corporation | $70.66 | 2025 | Navicross, Azur Cx Detachable |
| Novo Nordisk INC | $57.82 | 2024-2025 | Wegovy |
| Cardiva Medical, INC. | $46.66 | 2023-2025 | Cardiva Vascade 6/7f Vcs |
| Chiesi USA, INC. | $44.85 | 2024-2025 | Kengreal |
| Sirtex Medical INC | $31.83 | 2025 | Lava Les (Liquid Embolic System) |
| Shockwave Medical, INC | $27.40 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huasong Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.